Brief: Oncternal Therapeutics Q3 Net Income USD -9.862 Million
09/11/2023 21:01
Nov 09 (Reuters) - Oncternal Therapeutics Q3 basic EPS USD -0.17. * Q3 income from operations USD -10.39 million * Q3 operating expenses USD 10.569 million
Recent news on Oncternal Therapeutics
See all newsOncternal Therapeutics Inc expected to post a loss of $3.19 a share - Earnings Preview
Brief: Oncternal Therapeutics Workforce Reduction Of About 10 Employees
U.S. STOCKS ON THE MOVE-Unity Software, Viking Holdings, Adobe
U.S. STOCKS ON THE MOVE-Gold miners, silver miners, Warner Bros Discovery
Oncternal hits record low on plans to scrap studies, explore strategic alternatives;